Ovarian cancer: a heterogeneous disease

M Kossaï, A Leary, JY Scoazec, C Genestie - Pathobiology, 2018 - karger.com
Ovarian cancer encompasses a collection of neoplasms with distinct clinicopathological and
molecular features and prognosis. Despite there being a variety of ovarian cancer subtypes …

Vascular development and differentiation during human liver organogenesis

S Collardeau‐Frachon… - The Anatomical Record …, 2008 - Wiley Online Library
The vascular architecture of the human liver is established at the end of a complex
embryological history. The hepatic primordium emerges at the 4th week and is in contact …

[HTML][HTML] Laminin 332 in cancer: When the extracellular matrix turns signals from cell anchorage to cell movement

P Rousselle, JY Scoazec - Seminars in cancer biology, 2020 - Elsevier
Laminin 332 is crucial in the biology of epithelia. This large extracellular matrix protein
consists of the heterotrimeric assembly of three subunits–α3, β3, and γ2–and its …

[HTML][HTML] TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system

G Rindi, G Klöppel, XXH Alhman, M Caplin… - Virchows Archiv, 2006 - Springer
The need for standards in the management of patients with endocrine tumors of the
digestive system prompted the European Neuroendocrine Tumor Society (ENETS) to …

[HTML][HTML] Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing

F Ducimetière, A Lurkin, D Ranchère-Vince… - PloS one, 2011 - journals.plos.org
Background The exact overall incidence of sarcoma and sarcoma subtypes is not known.
The objective of the present population-based study was to determine this incidence in a …

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective …

R Sun, EJ Limkin, M Vakalopoulou, L Dercle… - The Lancet …, 2018 - thelancet.com
Background Because responses of patients with cancer to immunotherapy can vary in
success, innovative predictors of response to treatment are urgently needed to improve …

[HTML][HTML] A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization …

G Rindi, DS Klimstra, B Abedi-Ardekani, SL Asa… - Modern Pathology, 2018 - Elsevier
The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …

[PDF][PDF] Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC

J Zucman‐Rossi, E Jeannot, JT Van Nhieu… - …, 2006 - Wiley Online Library
Hepatocellular adenomas are benign tumors that can be difficult to diagnose. To refine their
classification, we performed a comprehensive analysis of their genetic, pathological, and …

High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial

C Massard, S Michiels, C Ferté, MC Le Deley, L Lacroix… - Cancer discovery, 2017 - AACR
High-throughput genomic analyses may improve outcomes in patients with advanced
cancers. MOSCATO 01 is a prospective clinical trial evaluating the clinical benefit of this …

ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes

RT Jensen, G Cadiot, ML Brandi, WW De Herder… - …, 2012 - karger.com
Gastrinomas are neuroendocrine neoplasms, usually located in the duodenum or pancreas,
that secrete gastrin and cause a clinical syndrome known as Zollinger-Ellison syndrome …